Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Buckey who wrote (105353)	5/17/2002 2:12:12 PM
From: Jim Bishop	Read Replies (1) \| Respond to of 150070

ADOT Advanced Optics Electronics Inc. Reports Progress in BIOMODA Inc. ALBUQUERQUE, N.M., May 17, 2002 (BUSINESS WIRE) -- Advanced Optics Electronics Inc. (OTC BB:ADOT) biotech investment BIOMODA Inc. of which ADOT holds approximately 17.5 percent reports that it has just received notification from the Canadian government of the granting of a patent for use of Tetrakis Porphine for the detecting and treating of lung cancer. This is a continuation of the BIOMODA Inc. program of obtaining patents on a global basis for its cancer detection technology. BIOMODA Inc. now holds international patents in addition to Canada in the following countries: Australia, Brazil, South Korea, Russia and Japan. ADOT also reports that it has made progress in preparing for BIOMODA Inc.'s IPO and is in the process of finalizing its preparation for its SB-2 filing. Advanced Optics Electronics Inc. is a technology company based in Albuquerque. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays utilizing its patented and patent-pending technology. In addition to the core business of ADOT, the company has made a strategic technology-oriented investment in BIOMODA Inc. BIOMODA Inc. (nonpublic) is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer. ADOT currently holds approximately 17 1/2 percent of BIOMODA Inc. This news release contains forward-looking statements that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q. CONTACT: Advanced Optics Electronics Inc., Albuquerque 505/797-7878 www.adotsite.com URL: businesswire.com Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. Copyright (C) 2002 Business Wire. All rights reserved. -0- KEYWORD: NEW MEXICO AUSTRALIA BRAZIL JAPAN RUSSIA SOUTH KOREA INDUSTRY KEYWORD: BIOTECHNOLOGY GOVERNMENT MANUFACTURING MEDICAL SOURCE: Advanced Optics Electronics Inc. * end of story *